Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis

Autor: Carolyn Deloa, Bruce C.A. Cree, Lisa F. Barcellos, Giovanni Savettieri, Antonio Uccelli, Stephen Sawcer, Jorge R. Oksenberg, Farren B.S. Briggs, Xavier Montalban, Patricia P. Ramsay, Margaret A. Pericak-Vance, Glenys Thomson, Pablo Villoslada, Ann B. Begovich, Robin R. Lincoln, Stephen L. Hauser, Jonathan L. Haines, Sergio E. Baranzini, Alastair Compston
Přispěvatelé: BARCELLOS LF, SAWCER S, RAMSAY PP, BARANZINI SE, THOMSON G, BRIGGS F, CREE BC, BEGOVICH AB, VILLOSLADA P, MONTALBAN X, UCCELLI A, SAVETTIERI G, LINCOLN RR, DELOA C, HAINES JL, PERICAK-VANCE MA, COMPSTON A, HAUSER SL, OKSENBERG JR
Jazyk: angličtina
Rok vydání: 2006
Předmět:
Models
Molecular

Male
Sequence Homology
immune system diseases
Models
Risk Factors
Databases
Genetic

Adult
Alleles
Amino Acid Sequence
Databases

Genetic
Female
Genetic Variation
Genotype
HLA-DR Antigens

chemistry/genetics
HLA-DRB1 Chains
Humans
Male
Middle Aged
Models

Molecular
Molecular Sequence Data
Multiple Sclerosis

Chronic Progressive
genetics/immunology
Multiple Sclerosis

genetics/immunology
Phenotype
Risk Factors
Sequence Homology

Amino Acid
skin and connective tissue diseases
HLA-DRB1
Genetics (clinical)
Genetics
General Medicine
Multiple Sclerosis
Chronic Progressive

Middle Aged
Phenotype
Female
musculoskeletal diseases
Adult
Multiple Sclerosis
Genotype
Molecular Sequence Data
Locus (genetics)
Human leukocyte antigen
Biology
Databases
Alleles
phenotype
heterogeneity
human leukocyte antigens
age of onset
chromosomes
genes
genotype
haplotypes
multiple sclerosis
relapsing-remitting
genetics
disability
primary progressive multiple sclerosis
hla-drb1 gene
illness length
severity of illness

Genetic
Genetic variation
medicine
Humans
Amino Acid Sequence
Allele
Molecular Biology
Alleles
Sequence Homology
Amino Acid

Multiple sclerosis
Haplotype
Genetic Variation
Molecular
HLA-DR Antigens
medicine.disease
genetics/immunology
chemistry/genetics
Immunology
Age of onset
HLA-DRB1 Chains
Popis: Variation in major histocompatibility complex genes on chromosome 6p21.3, specifically the human leukocyte antigen HLA-DR2 or DRB1*1501-DQB1*0602 extended haplotype, confers risk for multiple sclerosis (MS). Previous studies of DRB1 variation and both MS susceptibility and phenotypic expression have lacked statistical power to detect modest genotypic influences, and have demonstrated conflicting results. Results derived from analyses of 1339 MS families indicate DRB1 variation influences MS susceptibility in a complex manner. DRB1*15 was strongly associated in families (P=7.8x10(-31)), and a dominant DRB1*15 dose effect was confirmed (OR=7.5, 95% CI=4.4-13.0, P
Databáze: OpenAIRE